| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0097 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |